Parkinson’s disease is a progressive, degenerative disorder of the nervous system that affects more than 60,000 Americans each year. A group of researchers from Yonsei University in South Korea has discovered that the protection of nervous tissue may be facilitated by stem cells. Animals with Parkinson’s were injected with human mesenchymal stem cells. The treatment improved the animals’ cognitive behavior and suppressed alpha-synuclein, a toxic protein in the brain.
Additionally, the stem cells secreted galectin-1 that reacted with NMDA receptors, suppressing the intercellular transfer of alpha-synuclein. “At present, no drug can slow down the progress of the disease by suppressing the degeneration of the nervous system,” neurologist Lee Pil-hyu said, “However, the NMDA receptor, which is currently in use as a medicine for treating dementia and an anticonvulsant, can be developed into a drug for slowing down the natural progress of Parkinson’s disease.”
Yonsei University’s research is an example of the potential for regenerative stem cell therapies to effectively treat seemingly intractable, historically incurable conditions. To learn more about stem cells and how to insure immediate access to emerging personalized regenerative treatments by banking your own valuable dental pulp stem cells, please visit StemSave or call 877-783-6728 (877- StemSave) today.
The Future of Regenerative Medicine is Now™.
To view the full article, click here.